Highnoon Laboratories Limited (KASE: HINOON)
Health Care · Pharmaceuticals · PK
PKRs975.15
-1.24% today · -20.7% 1Y
Highnoon Laboratories Limited (KASE: HINOON) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $186.14M.
Over the last twelve months the share price has lost 20.7%, trading between 755.56 and 1.24K.
Tweenvest scores Highnoon Laboratories Limited across four factors: quality 86/100, value 62/100, growth 78/100, dividend 91/100. Its strongest factor is dividend.
HINOON price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $186.14M
- Revenue (TTM)
- $101.08M
- P/E
- 12.24
- EPS
- 79.68
- Dividend yield
- 5.06%
- Beta (5Y)
- 0.11
- 52-week high
- PKRs1,241.00
- 52-week low
- PKRs755.56
- Avg volume (3M)
- —
- Shares outstanding
- 52.98M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,243.44 | -0.28% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $270.51 | -0.93% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.36 | -0.20% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.30 | +0.24% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £122.24 | +0.94% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.92 | -0.18% |
Figures last refreshed Aug 18, 2026.